ProCE Banner Activity

Principles for Switching Antiretroviral Therapy: Determinants of ART Choice

Clinical Thought

Read my take on the factors to consider when contemplating a switch in antiretroviral therapy.

Released: October 11, 2022

Expiration: October 10, 2023

No longer available for credit.

Share

Faculty

Tristan J. Barber

Tristan J. Barber, MA, MD, FRCP

Consultant in HIV Medicine
Royal Free London NHS Foundation Trust
Honorary Associate Professor
Institute for Global Health
University College London
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

ViiV Healthcare

Faculty Disclosure

Primary Author

Tristan J. Barber, MA, MD, FRCP

Consultant in HIV Medicine
Royal Free London NHS Foundation Trust
Honorary Associate Professor
Institute for Global Health
University College London
London, United Kingdom

Tristan J. Barber, MA, MD, FRCP: consultant/advisor/speaker: Gilead Sciences, Merck, Roche, Theratechnologies, ViiV Healthcare; researcher: Roche, ViiV Healthcare; other financial or material support: Gilead Sciences.